Congenital, genetic, and endocrinologic influences on dental occlusion.
D000293:Adolescent; D000328:Adult; D000848:Anodontia / Q000150:complications; D001720:Birth Injuries / Q000150:complications; D002648:Child; D002675:Child, Preschool; D003766:Dental Occlusion; D004314:Down Syndrome / Q000150:complications; D004393:Dwarfism, Pituitary / Q000150:complications / Q000188:drug therapy; D004476:Ectodermal Dysplasia / Q000150:complications; D004700:Endocrine System Diseases / Q000150:complications; D005260:Female; D030342:Genetic Diseases, Inborn / Q000150:complications; D013006:Growth Hormone / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008310:Malocclusion / Q000209:etiology; D008445:Maxillofacial Development / Q000187:drug effects; D003765:Models, Dental; D009085:Mucopolysaccharidosis IV / Q000150:complications; D009136:Muscular Dystrophies / Q000150:complications / Q000235:genetics; D009805:Odontogenesis / Q000187:drug effects; D009912:Oral Manifestations; D011378:Prognathism / Q000209:etiology; D063173:Retrognathia / Q000209:etiology
D013006:Growth Hormone